PRTCYPureTech Health plcvs its industry peers
A metric-by-metric comparison of PureTech Health plc against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PRTCYEsta | — | — | — | — | 475.3%#1 | 181.4%#1 | -3154.0%#4 | 12.9%#1 | — | — | — | — |
| PRE | $369M#1 | — | 2.2x#3 | 12.1x#2 | 40.8%#3 | 26.2%#4 | -157.2%#1 | -27.2%#3 | — | — | — | — |
| PRENW | $187302#4 | — | 0.0x#1 | 0.0x#1 | 40.8%#3 | 26.2%#4 | -157.2%#1 | -27.2%#3 | — | — | — | — |
| PRFX | $855531#3 | — | 0.1x#2 | 50.3x#3 | — | 65.6%#3 | -30129.4%#6 | -58.8%#5 | — | — | — | — |
| PRQR | $196M#2 | — | — | — | — | — | — | — | — | — | — | — |
| PTCHF | — | — | — | — | 475.3%#1 | 181.4%#1 | -3154.0%#4 | 12.9%#1 | — | — | — | — |
| PVCT | — | — | — | — | -45.5%#5 | 15.6%#6 | -1575.3%#3 | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice